Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L I Janzén

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Mathematical Biosciences|November 7, 2017
Extending existing structural identifiability analysis methods to mixed-effects modelsDavid L I Janzén, Mats Jirstrand, Michael J Chappell, et al.
Computer Methods and Programs in Biomedicine|May 17, 2016
Three novel approaches to structural identifiability analysis in mixed-effects modelsDavid L I Janzén, Mats Jirstrand, Michael J Chappell, et al.
BMC Systems Biology|September 4, 2015
Nonlinear mixed-effects modelling for single cell estimation: when, why, and how to use itMarkus Karlsson, David L I Janzén, Lucia Durrieu, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 28, 2017
Translational model to predict pulmonary pharmacokinetics and efficacy in man for inhaled bronchodilatorsRamon Hendrickx, Eva Lamm Bergström, David L I Janzén, et al.
Frontiers in Bioengineering and Biotechnology|May 5, 2017
Input Estimation for Extended-Release Formulations Exemplified with ExenatideMagnus Trägårdh, Michael J Chappell, Johan E Palm, et al.
Frontiers in Physiology|December 21, 2016
Parameter Identifiability of Fundamental Pharmacodynamic ModelsDavid L I Janzén, Linnéa Bergenholm, Mats Jirstrand, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Mathematical Biosciences|November 7, 2017
Extending existing structural identifiability analysis methods to mixed-effects modelsDavid L I Janzén, Mats Jirstrand, Michael J Chappell, et al.
Computer Methods and Programs in Biomedicine|May 17, 2016
Three novel approaches to structural identifiability analysis in mixed-effects modelsDavid L I Janzén, Mats Jirstrand, Michael J Chappell, et al.
BMC Systems Biology|September 4, 2015
Nonlinear mixed-effects modelling for single cell estimation: when, why, and how to use itMarkus Karlsson, David L I Janzén, Lucia Durrieu, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 28, 2017
Translational model to predict pulmonary pharmacokinetics and efficacy in man for inhaled bronchodilatorsRamon Hendrickx, Eva Lamm Bergström, David L I Janzén, et al.
Frontiers in Bioengineering and Biotechnology|May 5, 2017
Input Estimation for Extended-Release Formulations Exemplified with ExenatideMagnus Trägårdh, Michael J Chappell, Johan E Palm, et al.
Frontiers in Physiology|December 21, 2016
Parameter Identifiability of Fundamental Pharmacodynamic ModelsDavid L I Janzén, Linnéa Bergenholm, Mats Jirstrand, et al.
Pageof 1